Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 3
1958 2
1966 1
1969 3
1971 1
1972 1
1973 1
1974 1
1975 2
1976 3
1978 3
1979 2
1980 4
1981 7
1982 6
1983 12
1984 7
1985 10
1986 16
1987 7
1988 11
1989 10
1990 10
1991 7
1992 7
1993 11
1994 10
1995 7
1996 6
1997 9
1998 13
1999 11
2000 14
2001 13
2002 6
2003 12
2004 21
2005 24
2006 34
2007 27
2008 31
2009 30
2010 14
2011 12
2012 21
2013 19
2014 22
2015 23
2016 7
2017 13
2018 13
2019 11
2020 8
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 17555784

541 results
Results by year
Filters applied: . Clear all
Page 1
The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. Hirose A, et al. Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. doi: 10.1016/j.taap.2007.03.031. Epub 2007 Apr 20. Toxicol Appl Pharmacol. 2007. PMID: 17555784
Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.
Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. Shigama K, et al. J Exp Ther Oncol. 2009;8(1):43-51. J Exp Ther Oncol. 2009. PMID: 19827270
Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.
Lee CK, Son SH, Park KK, Park JH, Lim SS, Kim SH, Chung WY. Lee CK, et al. Basic Clin Pharmacol Toxicol. 2008 Jul;103(1):48-54. doi: 10.1111/j.1742-7843.2008.00238.x. Epub 2008 Jul 1. Basic Clin Pharmacol Toxicol. 2008. PMID: 18484961 Free article.
Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
Lee CK, Park KK, Hwang JK, Lee SK, Chung WY. Lee CK, et al. Phytother Res. 2009 Jul;23(7):999-1005. doi: 10.1002/ptr.2740. Phytother Res. 2009. PMID: 19140122
5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Tikoo K, Ali IY, Gupta J, Gupta C. Tikoo K, et al. Toxicol Lett. 2009 Dec 15;191(2-3):158-66. doi: 10.1016/j.toxlet.2009.08.018. Epub 2009 Aug 31. Toxicol Lett. 2009. PMID: 19723570
Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
Dominguez MF, Macias RI, Izco-Basurko I, de La Fuente A, Pascual MJ, Criado JM, Monte MJ, Yajeya J, Marin JJ. Dominguez MF, et al. J Pharmacol Exp Ther. 2001 Jun;297(3):1106-12. J Pharmacol Exp Ther. 2001. PMID: 11356935
Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.
Nogusa S, Gerbino J, Ritz BW. Nogusa S, et al. Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005. Nutr Res. 2009. PMID: 19285605
Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.
Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z. Gao Y, et al. Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. doi: 10.1007/s00262-005-0111-9. Epub 2005 Dec 16. Cancer Immunol Immunother. 2006. PMID: 16362410
Magnesium depletion enhances cisplatin-induced nephrotoxicity.
Lajer H, Kristensen M, Hansen HH, Nielsen S, Frøkiaer J, Ostergaard LF, Christensen S, Daugaard G, Jonassen TE. Lajer H, et al. Cancer Chemother Pharmacol. 2005 Nov;56(5):535-42. doi: 10.1007/s00280-005-1010-7. Epub 2005 Jun 10. Cancer Chemother Pharmacol. 2005. PMID: 15947931
Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice.
Masuda Y, Inoue M, Miyata A, Mizuno S, Nanba H. Masuda Y, et al. Int Immunopharmacol. 2009 May;9(5):620-6. doi: 10.1016/j.intimp.2009.02.005. Epub 2009 Feb 26. Int Immunopharmacol. 2009. PMID: 19249389
541 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page